Genus plc
GNS
Rank in Stocks
#5765
Genus plc is a global animal genetics company with operations spanning North... Genus plc is a global animal genetics company with operations spanning North America, Latin America, the UK, continental Europe, the Middle East, Russia, Africa, and Asia. The business is divided into three key segments: Genus PIC, Genus ABS, and Genus Research and Development. Under its PIC brand, the company provides breeding stock, including sows, boars, and semen, to develop pigs with specific characteristics optimized for pork production. Similarly, for cattle, its ABS, Genus, and Bovec brands offer bull semen and embryos designed to produce calves with advantageous traits for either milk or beef output. Farmers also benefit from a range of specialized technical services, such as semen sexing and reproductive solutions. Genus plc is also strategically collaborating with Beijing Capital Agribusiness Co. Ltd on the research, development, and regulatory approval of porcine reproductive and respiratory syndrome virus (PRRSV)-resistant pigs in China. The company was established in 1994 and is based in Basingstoke, United Kingdom.
Share Price
$32.39
Last synced: 2026-11-09
Market Cap
$2.09B
Change (1 day)
1.35%
Change (1 year)
3.43%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Genus plc (GNS)
Category
Healthcare
EPS for Genus plc (GNS)
EPS as of June 2026 TTM: $5.74
According to Genus plc's latest financial reports, its current EPS (TTM) is $5.74. At the end of 2025 the company had an EPS of $0.40, an increase over its 2024 EPS of $0.15.
EPS history for Genus plc from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $5.74 | 1,335.43% |
| 2025 | $0.40 | 162.32% |
| 2024 | $0.15 | -76.57% |
| 2023 | $0.65 | -15.42% |
| 2022 | $0.77 | -24.12% |
| 2021 | $1.01 | 50.91% |
| 2020 | $0.67 | 339.26% |
| 2019 | $0.15 | -83.52% |
| 2018 | $0.92 | 31.42% |
| 2017 | $0.70 | -34.71% |
| 2016 | $1.08 | 3.98% |
| 2015 | $1.04 | 26.18% |
| 2014 | $0.82 | 38.44% |
| 2013 | $0.59 | -42.60% |
| 2012 | $1.03 | 31.46% |
| 2011 | $0.79 | 14.14% |
| 2010 | $0.69 | 39.05% |
| 2009 | $0.50 | -19.78% |
| 2008 | $0.62 | 14.00% |
| 2007 | $0.54 | 72.73% |
| 2006 | $0.31 | 3.84% |
| 2005 | $0.30 | 2.55% |
| 2004 | $0.29 | 124.39% |
| 2003 | $0.13 | 442.15% |
| 2002 | $0.02 | -63.77% |
| 2001 | $0.07 | -61.92% |
| 2000 | $0.18 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | 172.74% |
US
|
|
| $-7.07 | -223.13% |
US
|
|
| $-5.29 | -192.13% |
AU
|
|
| $12.88 | 124.33% |
BE
|
|
| $21.56 | 275.50% |
NL
|
Questions about Genus plc's earnings per share (EPS)
What is Genus plc's earnings per share (EPS)?
Genus plc's earnings per share (EPS) over the last twelve months is $5.74, as of Jun 2026.
What was Genus plc's earnings per share (EPS) in 2025?
In 2025, Genus plc's earnings per share (EPS) was $0.40, 166.67% more than in 2024 ($0.15).
How has Genus plc's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Genus plc's earnings per share (EPS) went from $0.67 to $0.40, an average decline of 9.80% a year.
How does Genus plc's earnings per share (EPS) compare with similar companies?
Genus plc's earnings per share (EPS) ($5.74) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.